FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine, namely to oral gindarine medicine characterised as a tranquilizer. Said medicine contains gindarine hydrochloride as an active material and auxiliary components and represents a solid gelatinous capsule. Gindarine is included as a compound of the mass filling capsules as mixed powders of gindarine and auxiliary components or as a granulated material. As the auxiliary components, the medicine contains bulking agent either alone, or combined with a disintegrant or antifriction material or with their mixture. There is also provided method of production of specified oral medicine.
EFFECT: invention provides simplified technological process for making the gindarine medicine, reduction of defective goods, reduced production cost, higher bioavailability of gindarine in comparison with a tableted medical product.
4 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
GINDARINE COMPOSITION | 2007 |
|
RU2372912C2 |
ORAL PHARMACEUTICAL COMPOSITION MEMANTIN (OPTIONS) AND METHOD OF PREPARATION (OPTIONS) | 2007 |
|
RU2326660C1 |
PERORAL MEDICINE TILORONE | 2007 |
|
RU2336073C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF SOLID PERORAL MEDICINAL FORM, CONTAINING SYGETHINUM (VERSIONS) | 2007 |
|
RU2338523C1 |
ENCAPSULATED ANTIVIRAL MEDICATION AND ITS PRODUCTION METHOD | 2011 |
|
RU2451514C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
DRUG PREPARATION IN FORM OF CAPSULES EXHIBITING ANTIVIRAL AND INTERFERONOGENIC ACTION | 2010 |
|
RU2446803C1 |
SYGETIN BASED PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2346684C2 |
PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING AND USING DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION CONTAINING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2021 |
|
RU2818092C1 |
Authors
Dates
2009-07-10—Published
2007-12-28—Filed